Nuance is a Shanghai headquartered specialty care focused biopharma company focusing on respiratory, pain management and iron deficiency areas. With the mission to address critical unmet medical needs in Greater China and AsiaPac, since inception from 2014, Nuance has built a late clinical stage portfolio under development focusing on key therapeutic areas through global partnerships, while maintaining a self-sustainable commercial operation. To learn more, please visit nuancepharma.comLed the business development and M&A activities of Nuance, building portfolio comprising of commercial assets and innovative development stage pipeline. Through alliance management and launch excellence preparation, drove the progress of pipeline from late stage development to commercialization. Managed critical growth pillars (e.g., retail) and enabling functions (e.g., market access) for established commercial business. Led the Asia expansion effort to extend business operations beyond mainland China.

As the marketing director of the GastroIntestinal Business Unit ($500M+ annual revenue), developed and implemented growth strategy for products at different life cycle stages (VBP impacted, NRDL reimbursed) across channels (hospitals, retails, internet hospitals, etc.), leading central and regional teams. Led new product planning, business development and ecosystem partnership activities for the BU, finalized multiple CSO deals. Explored the cross-selling models for drug and medical devices.

Co-leader of McKinsey China healthcare practice. Advised leading multinational and local biopharma companies on their China and more broader Asia strategies. Focused on providing consulting service to senior management teams on a broad range of strategic topics, covering growth (e.g., new product launch, business development), innovation (e.g., ecosystem partnership, digital transformation) and organization (e.g., capability building, organization agility).